A Multicenter Randomized Double-Blinded Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

Study Overview

The purpose of this research study is to investigate the safety and how well inhaled treprostinil works in subjects with pulmonary hypertension (PH) associated with interstitial lung disease (ILD) or combined pulmonary fibrosis and emphysema (CPFE).

Study Description

The purpose of this study is to investigate the safety and how well inhaled treprostinil works in subjects with WHO Group 3 PH.

Additional Information

Participants will be paid for their participation.

IRB Number: 1602009422
Research Study Identifier: TX6365
Principal Investigator: William Harvey, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

* Your Email

* First Name

Last Name

* Your Phone

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Recruitment Status

Open

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176

A Multicenter Randomized Double-Blinded Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

Study Overview

Study Description

Additional Information

Recruitment Status

Contact the research team to learn more about this study.

Recruitment Status

Volunteer Registry